HIGHLIGHTS   |  February 22, 2020   Staging Guidelines May be Missing Biomarkers that Affect Outcomes in OPSCC Researchers suggested that the 2017 classifications do not currently allow for uniform stratification and proper outcome prognostication for surgically treated patients with p16-positive oropharyngeal squamous cell carcinoma. Read more   FDA Grants Priority Review to Lurbinectedin to Treat Small Cell Lung Cancer The FDA granted a priority review to the new drug application for lurbinectedin as a treatment for patients with small cell lung cancer. Read more   In Case You Missed It

Using HDAC3 Inhibitors to Reverse CREBBP Mutations in Lymphomas This research could potentially pave the way for possible immunotherapy approaches for common forms of non-Hodgkin lymphoma. Read more